CRL vs GFF · rev $2.00B vs P/E 15, rev $2.52B
Charles River Laboratories (CRL) versus Griffon Corporation (GFF) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Griffon Corporation (GFF) is a building products & equipment company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GFF revenue for 2025-09-30 was $2.52B. Net income was $51.1M. GFF currently screens at market cap $3.40B and trailing P/E 15.0.
CRL currently screens at market cap $7.78B. GFF currently screens at market cap $3.40B and trailing P/E 15.0.
Not investment advice. Open the CRL and GFF stock pages for the full models.
Not investment advice.